.
MergerLinks Header Logo

New Deal


Announced

Completed

IM Cannabis completed the acquisition of MYM Nutraceuticals.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium17.9%
One Off Charge-

Tags

Edit

Single Bidder

Completed

biopharmaceuticals

Majority

Canada

Acquisition

Friendly

Cross Border

Pharmaceuticals

Public

Synopsis

Edit

IM Cannabis, a Canada-based international medical cannabis company, completed the acquisition of MYM Nutraceuticals, a Canada based company engaged in the business of acquiring and developing natural remedies. Financial terms were not disclosed. “Acquiring MYM is consistent with IMC’s focus on premium and super premium segments of the cannabis market for consumers and patients in all markets. The Transaction also demonstrates our disciplined approach to acquiring accretive companies that create financial and operational synergies and result in additional opportunities to export premium cannabis products to Israel and Germany. With coast-to-coast distribution, including a strong leadership position in Eastern Canada, Highland Grow will further enhance our distribution capabilities and fast-track our entrance into new markets," Oren Shuster, IMC CEO.

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US